C-19 Coronavirus Deaths are Over Counted by the Doom Doctors for Financial Gain

C-19 Coronavirus Deaths are Over Counted by the Doom Doctors for Financial Gain

Over 86,500 people have reportedly died in the United States from the Coronavirus, and the fear generated by those deaths is driving the public policy debate.

But that number is a huge overcount, as metrics include deaths that have nothing to do with the virus. The problem is even worse as the Centers for Disease Control (CDC) over counts even some of these cases and the government has created financial incentives for this misreporting.

Relying on these flawed numbers is destroying businesses and jobs and costing lives.

Coronavirus deaths not only are being counted erroneously, but in some cases are 2X counted, according to 2 board members for the Crime Prevention Research Center.

On Top of that, deaths that have nothing to do with C-19 coronavirus are also being included in the count because of financial incentives to do it.

The errors and overcounting are destroying jobs and costing lives, John R. Lott Jr. and Dr. Timothy Craig Allen say in a dramatic op-ed they wrote for Townhall.

Mr. Lott is President of the research center, and Mr. Allen is on the center’s academic advisory board and chair of the department of pathology at the University of Mississippi Medical Center.

One example they give is that hospice patients who are already dying, but are positive for SARS-CoV-2 at time of death, are being listed as coronavirus deaths, rather than the real reason they were in hospice in the 1st place.

New York is classifying cases as Coronavirus deaths even when postmortem tests have been negative. Despite negative tests, classifications are based on symptoms, even though the symptoms are often very similar to those of the seasonal flu.

The Centers for Disease Control guidance explicitly acknowledges the uncertainty that Doctors face. When Coronavirus cases are “suspected,” they advise Doctors that “it is acceptable to report COVID-19 on a death certificate.”

That is not just a theoretical issue.

On 21 April, when New York City’s death toll rose above 10,000, the NY-Ts reported that the city included “3,700 additional people who were presumed to have died of the coronavirus but had never tested positive” – a more than 50% increase in the number of cases.

Incentives matter

There are additional reasons for concern. Some doctors feel pressure from hospitals to list deaths as due to the Coronavirus, even when they do not believe that is the case, “to make it look a little bit worse than it is.”

There are financial incentives that might make a difference for hospitals and doctors. The CARES Act adds a 20% premium for C-19 coronavirus Medicare patients. 

When the government increased the disability compensation for air traffic controllers, a lot more controllers suddenly started claiming to be disabled. When unemployment insurance payments increase, more people become unemployed and stay unemployed for longer periods. When the government offers flood insurance that charges everyone the same insurance premium regardless of the risk level in their area, more people build homes in frequently flooded areas.

Erroneous data scares people about the risks of the disease. It keeps the country locked down longer than necessary, which destroys people’s’ lives and livelihoods in many other ways.

Exaggerated fears of the virus endanger lives by keeping people from obtaining treatment for other medical problems.  It also makes it impossible to accurately compare policies across countries. 

It is hard to believe that we are basing such crucial decisions on such flawed data.

The Big Q: What is the reason for this Medical Malpractice?

Stay tuned…

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge. Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.